Dr Susanne Braum will join INFORS HT as the Managing Director for its German subsidiary Infors GmbH. Susanne is a seasoned expert in medical and laboratory systems for the international life science industry and her appointment will further strengthen the capability of INFORS HT to serve its German customers. Dr Susanne Braum will take-over the […]
Mission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Platforms and Portfolio Expansion via Strategic Acquisitions Dr. Michael Egholm, Former CTO of Danaher Life Sciences, to Assume Role of CEO and Join Board of Directors Following Close; Alex Kim, Former President of Milliken & Company’s Healthcare Division, to Assume Role of COO Eli Casdin, CIO […]
Sean Kearney Joins Executive Team to Help Drive Continued Growth in Genomic Data Business ANN ARBOR, MICH. — Following a year of 125% revenue growth, Genomenon®, Inc., an AI-driven genomics company, today announced that Sean Kearney has been appointed Chief Financial Officer (CFO), effective immediately. As a valuable member of Genomenon’s executive leadership team, Mr. Kearney […]
Ms. Moy brings 30 years of HR leadership experience at high-performing companies MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Marilee Moy as Chief People Officer. Ms. Moy has more than 30 years of HR leadership experience at high-performing life sciences and technology companies. She […]
LAUSANNE, Switzerland – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced the appointment of Janis M. Taube, M.D., M.Sc., a leading pathologist and expert on immunotherapy research, to its Scientific Advisory Board. As an advisor, Dr. Taube will provide strategic advisory support to Lunaphore’s scientific activities and product […]
Genomics Industry Veteran to Spearhead Commercialization of Disruptive Platform that will Increase Access to Single Cell Samples and Accelerate Market Adoption SAN DIEGO, Calif. and CAMBRIDGE, UK – CS Genetics, a privately held genomics-technology company, today announced the appointment of Jeremy Preston, PhD, as Chief Commercial Officer. Jeremy will lead global sales, marketing, and customer-support activities as […]
Accelerates company’s long-term growth strategy and the evolution of its industry-leading clinico-genomic data capabilities TAMPA, FL — M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry leading data and analytics, today announced that it has expanded its executive team with the appointments of Daniel Elgort, Ph.D., as Chief Data and Analytics Officer and May Yoon as […]
MENLO PARK, Calif. — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate, sequencing platforms, welcomes Lara Toerien, Ph.D., as Vice President and General Manager for the company’s Americas region. Lara will be responsible for leading and developing PacBio’s commercial organization within North and South America while furthering its growth and market presence throughout the […]
Former Beyond Meat COO and CFO, Mark J. Nelson joins SnapDNA’s Board of Directors Broomfield, CO—SnapDNA today announced the appointment of Mark J. Nelson to the SnapDNA Board of Directors. “We are pleased to welcome Mr. Nelson to the SnapDNA Board”, said David Medin, Chairman and Chief Executive Officer of SnapDNA. “Mark’s deep experience in […]
RYE BROOK, N.Y. — Xylem Inc. (NYSE: XYL), a leading global water technology company, today announced the appointment of Dorothy Capers as Senior Vice President, General Counsel, effective February 7, 2022. Current General Counsel, Claudia Toussaint, has assumed the dual responsibilities of Chief Human Resources and Sustainability Officer, a newly combined position supporting the Company’s […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
